ArticleHealth science reports2025
Scientometric Study of Mpox and Vaccine Research: Dynamics, Emerging Patterns, and Networking.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- First Comprehensive Global Bibliometric Analysis of Monkeypox Virus Research Landscape From 1976 to 2025.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Mpox (Monkeypox) is a zoonotic disease transmitted through contact with infected animals or humans. Recent research focuses on epidemiology, transmission, and vaccine development to combat its resurgence. This bibliometric study analyzed the dynamics, emerging patterns, and networks of mpox and vaccine research from 2019 to 2024. Methods: The literature search was conducted in the Scopus database on August 18, 2024, initially identifying 1278 papers published between January 2019 and August 2024. A specific search strategy was applied to collect documents. The retrieved documents were analyzed using the Scival and Bibliometrix tools to obtain bibliometric metrics. Data analysis was performed using R Studio and Scival. Results: During the study period, 562 sources were identified that contributed to 1278 papers on mpox and vaccine research. These papers show an impressive annual growth rate of 91.49%. Several institutions stood out for their contributions to mpox and vaccine research. The journal Vaccines had 58 publications, followed by the Journal of Medical Virology and Vaccine with 31 publications each. According to Bradford's law, in Zone 1, the journal Vaccines had 58 publications. According to Lotka's law, most authors in the field of mpox and vaccine research have written only one article. Conclusion: These findings highlight the diversity of sources contributing to the mpox and vaccine research literature and highlight the importance of these sources in terms of their scholarly impact and relevance to the research community. This study provides valuable insight into emerging trends and patterns in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.